Correlation Between Dev Information and Krebs Biochemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dev Information and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dev Information and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dev Information Technology and Krebs Biochemicals and, you can compare the effects of market volatilities on Dev Information and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dev Information with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dev Information and Krebs Biochemicals.

Diversification Opportunities for Dev Information and Krebs Biochemicals

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Dev and Krebs is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Dev Information Technology and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and Dev Information is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dev Information Technology are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of Dev Information i.e., Dev Information and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between Dev Information and Krebs Biochemicals

Assuming the 90 days trading horizon Dev Information Technology is expected to generate 0.9 times more return on investment than Krebs Biochemicals. However, Dev Information Technology is 1.11 times less risky than Krebs Biochemicals. It trades about -0.03 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about -0.03 per unit of risk. If you would invest  16,120  in Dev Information Technology on October 30, 2024 and sell it today you would lose (990.00) from holding Dev Information Technology or give up 6.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dev Information Technology  vs.  Krebs Biochemicals and

 Performance 
       Timeline  
Dev Information Tech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dev Information Technology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Dev Information may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Krebs Biochemicals and 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Dev Information and Krebs Biochemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dev Information and Krebs Biochemicals

The main advantage of trading using opposite Dev Information and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dev Information position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.
The idea behind Dev Information Technology and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm